Ironwood Financial’s GSK GSK Stock Holding History

Ironwood Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Hold	4,985	–	–	0.04%	161
2026 Q1	$275K	Hold	4,985	–	–	0.05%	146
2025 Q4	$251K	Hold	4,985	–	–	0.04%	154
2025 Q3	$215K	Buy	+4,985	New	+$195K	0.04%	158
2024 Q4	–	Sell	-4,985	Closed	-$204K	–	159
2024 Q3	$204K	Sell	4,985 -760	-13%	-$31.1K	0.04%	146
2024 Q2	$221K	Hold	5,745	–	–	0.05%	140
2024 Q1	$246K	Hold	5,745	–	–	0.06%	141
2023 Q4	$213K	Hold	5,745	–	–	0.05%	141
2023 Q3	$208K	Hold	5,745	–	–	0.06%	139
2023 Q2	$205K	Sell	5,745 -3,456	-38%	-$124K	0.05%	136
2023 Q1	$327K	Hold	9,201	–	–	0.09%	114
2022 Q4	$323K	Hold	9,201	–	–	0.1%	115
2022 Q3	$271K	Buy	+9,201	New	+$349K	0.09%	102
2022 Q2	–	Sell	-9,204	Closed	-$501K	–	119
2022 Q1	$501K	Hold	9,204	–	–	0.14%	79
2021 Q4	$507K	Hold	9,204	–	–	0.14%	82
2021 Q3	$440K	Buy	9,204 +994	+12%	+$49.9K	0.13%	86
2021 Q2	$409K	Hold	8,210	–	–	0.12%	87
2021 Q1	$366K	Hold	8,210	–	–	0.12%	88
2020 Q4	$378K	Buy	+8,210	New	+$377K	0.14%	81

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ironwood Financial's GSK Position: Q2 2026 in Review

Ironwood Financial held its GSK (GSK) position steady in Q2 2026 at 4,985 shares worth $261K. The position accounts for 0.04% of the portfolio, ranked #161.

Ironwood Financial first reported a position in GSK in Q4 2020 and has held it in 19 quarters since. The position peaked at $507K in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Ironwood Financial held 4,985 shares of GSK worth $261K as of Q2 2026.
Ironwood Financial left its GSK share count unchanged in Q2 2026.
GSK made up 0.04% of Ironwood Financial's portfolio in Q2 2026, its #161 holding.
Ironwood Financial first reported a position in GSK in Q4 2020 and has held it in 19 quarters since.
Ironwood Financial's GSK position peaked at $507K in Q4 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ironwood Financial's 13F filing for Q2 2026, filed 17 Jul 2026.